DK694687A - Hidtil ukendte oligosaccharider, immunogener og vacciner og fremgangsmaader til fremstilling af disseoligosaccharider, immunogener og vacciner - Google Patents

Hidtil ukendte oligosaccharider, immunogener og vacciner og fremgangsmaader til fremstilling af disseoligosaccharider, immunogener og vacciner

Info

Publication number
DK694687A
DK694687A DK694687A DK694687A DK694687A DK 694687 A DK694687 A DK 694687A DK 694687 A DK694687 A DK 694687A DK 694687 A DK694687 A DK 694687A DK 694687 A DK694687 A DK 694687A
Authority
DK
Denmark
Prior art keywords
immunogens
vaccines
unknown
oligosaccharides
disseoligosaccharides
Prior art date
Application number
DK694687A
Other languages
English (en)
Other versions
DK694687D0 (da
Inventor
Eduar Coen Beuvery
Adolf Evenberg
Jan Theunis Poolman
Jacobus Hubertus Van Boom
Peter Hoogerhout
Constant Adriaan Anton Boeckel
Original Assignee
Nederlanden Staat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Staat filed Critical Nederlanden Staat
Publication of DK694687D0 publication Critical patent/DK694687D0/da
Publication of DK694687A publication Critical patent/DK694687A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK694687A 1986-12-31 1987-12-30 Hidtil ukendte oligosaccharider, immunogener og vacciner og fremgangsmaader til fremstilling af disseoligosaccharider, immunogener og vacciner DK694687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8603325 1986-12-31

Publications (2)

Publication Number Publication Date
DK694687D0 DK694687D0 (da) 1987-12-30
DK694687A true DK694687A (da) 1988-07-01

Family

ID=19849078

Family Applications (1)

Application Number Title Priority Date Filing Date
DK694687A DK694687A (da) 1986-12-31 1987-12-30 Hidtil ukendte oligosaccharider, immunogener og vacciner og fremgangsmaader til fremstilling af disseoligosaccharider, immunogener og vacciner

Country Status (15)

Country Link
US (1) US5034519A (da)
EP (1) EP0276516B1 (da)
JP (1) JPS63190896A (da)
KR (1) KR880007557A (da)
AT (1) ATE87003T1 (da)
AU (1) AU603405B2 (da)
CA (1) CA1335405C (da)
DE (1) DE3784907T2 (da)
DK (1) DK694687A (da)
ES (1) ES2054657T3 (da)
FI (1) FI89172C (da)
IE (1) IE59734B1 (da)
NO (1) NO169775C (da)
NZ (1) NZ223009A (da)
PT (1) PT86484B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
ATE105189T1 (de) * 1988-04-19 1994-05-15 American Cyanamid Co Haemophilus influenzae typ b polysaccharidaussermembranprotein-konjugat als impfstoff.
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
EP0378929A3 (en) * 1988-12-23 1990-08-01 Connaught Laboratories Limited Membrane proteins and peptides of haemophilus influenzae type b
GB8924473D0 (en) * 1989-10-31 1989-12-20 Connaught Lab Outer membrane protein p1 and peptides of haemophilus influenzae b
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
ES2131066T3 (es) * 1990-12-21 1999-07-16 Antex Biolog Inc Vacuna de conjugacion de oligosacarido con adhesina para hi(haemophilus influenzae).
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
DE69126522T2 (de) * 1991-05-20 1997-11-06 Kao Corp Neue Phosphobetain und die enthaltende Detergenz und Cosmetica
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
WO1994000152A1 (en) * 1992-06-25 1994-01-06 Georgetown University Papillomavirus vaccines
US7148031B2 (en) 1994-07-26 2006-12-12 The Mitre Corporation Sequestering of glycoprotein molecules and oligosaccharide moieties in lipo-glycoprotein membranes and micelles
US5762256A (en) 1995-08-28 1998-06-09 United States Surgical Corporation Surgical stapler
US5782396A (en) 1995-08-28 1998-07-21 United States Surgical Corporation Surgical stapler
US6032849A (en) * 1995-08-28 2000-03-07 United States Surgical Surgical stapler
SE9601158D0 (sv) * 1996-03-26 1996-03-26 Stefan Svenson Method of producing immunogenic products and vaccines
JP4162267B2 (ja) * 1996-08-27 2008-10-08 カイロン コーポレイション Ｎｅｉｓｓｅｒｉａ ｍｅｎｉｎｇｉｔｉｄｉｓ血清型Ｂ複合糖質およびその使用法
US6267961B1 (en) * 1996-11-22 2001-07-31 Baxter International Inc. Direct methods for molar-mass determination of fragments of Haemophilus influenzae type b capsular polysaccharides and vaccine preparation
CU22904A1 (es) * 1999-08-30 2004-01-23 Univ De Ottawa Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos
US8785134B2 (en) 2008-11-10 2014-07-22 The Mitre Corporation Glycoprotein vesicles and their methods of use
MX2019001167A (es) 2016-07-28 2019-09-16 Max Planck Gesellschaft Derivados sinteticos estables de poliribosilribitolfosfato resistentes a la hidrolisis como vacunas contra haemophilus influenzae tipo b.
CN108776223B (zh) * 2018-04-19 2021-04-06 广州质量监督检测研究院 紫外吸收剂uv-326检测试剂盒及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine

Also Published As

Publication number Publication date
PT86484B (pt) 1990-11-20
DE3784907T2 (de) 1993-06-24
EP0276516B1 (en) 1993-03-17
FI89172B (fi) 1993-05-14
NO875442D0 (no) 1987-12-28
ES2054657T3 (es) 1994-08-16
AU8314587A (en) 1988-07-07
US5034519A (en) 1991-07-23
AU603405B2 (en) 1990-11-15
DE3784907D1 (de) 1993-04-22
FI89172C (fi) 1993-08-25
NZ223009A (en) 1990-06-26
NO169775B (no) 1992-04-27
EP0276516A3 (en) 1988-08-17
JPS63190896A (ja) 1988-08-08
PT86484A (en) 1988-01-01
KR880007557A (ko) 1988-08-27
NO169775C (no) 1992-08-05
EP0276516A2 (en) 1988-08-03
IE59734B1 (en) 1994-03-23
FI875727A (fi) 1988-07-01
ATE87003T1 (de) 1993-04-15
DK694687D0 (da) 1987-12-30
CA1335405C (en) 1995-04-25
FI875727A0 (fi) 1987-12-28
IE873510L (en) 1988-06-30
NO875442L (no) 1988-07-01

Similar Documents

Publication Publication Date Title
DK694687A (da) Hidtil ukendte oligosaccharider, immunogener og vacciner og fremgangsmaader til fremstilling af disseoligosaccharider, immunogener og vacciner
FR2499412B1 (fr) Production de vaccin antivirus
DK497488D0 (da) 6-(((substituerede)-pyridin-3-yl)-alkyl)- og alkenyl)- tetrahydro-4-hydroxypyran-2-on-derivater og ffremgangsmaade til fremstilling deraf
IT1205820B (it) Adiuvante immunologico per vaccini polisaccaridici
UA5571A1 (uk) СПОСІБ ОДЕРЖАННЯ 2-БРОМ-alРha-ЕРГОКРІПТІНУ АБО ЙОГО КИСЛОТНО-АДІТИВНИХ СОЛЕЙ
DK154087A (da) Fremgangsmaade til fremstilling af c-20-amino-substituerede makrolid-derivater
PT70610A (fr) Procede de preparation de proteoglycanes bacteriens destines a etre incorpores avec un vaccin et vaccin qui les contient
LU80063A1 (fr) Procede de preparation d'un vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c
DK0515415T3 (da) Hidtil ukendt vaccine og fremgangsmåde til fremstilling deraf
DK592284D0 (da) Toxoid, vaccinepraeparat indeholdende det og fremgangsmaade til fremstilling af det
NO174085C (no) Fremgangsmåte for fremstilling av sukralfatpreparater
FI871131A (fi) Menetelmä rokotteen valmistamiseksi
DK42083D0 (da) Fremgangsmade til fremstilling af et immunogen af pasteurella multocida
DK621688D0 (da) Ethylerede avermectiner og praeparater indeholdende disse til behandling og forhindring af parasitinfektioner hos mennesker og dyr
DK343988D0 (da) Praeparater med kontrolleret afgivelseshastighed af nulte orden, og fremgangsmaade til fremstilling af saasanne praeparater
PT86745A (pt) Process for preparing oxime ethers of 2,6-dioxabicyclo ]3.3.o" octanones
DK315487D0 (da) Methylenderivater af androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf
NO875465D0 (no) Fremgangsmaate for fremstilling av aminoalkanoyl-dibenzo(d,g)(1,3,6)dioxazociner.
PT88465A (pt) Process for the preparation of macrolide compounds
NO882224D0 (no) Fremgangsmaate for fremstilling av analoger av alfa-msh.
DK598184A (da) 3-aryl-1,2-benzisoxazolsulfonyl- og -sulfinylalkansyrer og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse som laegemidler
IT1113320B (it) Metodo perfezionamto per la preparazione del carburo di silicio
IT1167477B (it) Processo per la preparazione della 2,6-bis(n-(alfa-benzoiltio)propionilglicinossimetil)piridina
IT1201898B (it) Procedimento per la decorazione di prodotti ottenuti per sublimazione, particolarmente per sci
DK156052C (da) Fremgangsmaade til fremstilling af n,n,n',n'-tetraacetylethylendiamin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment